288. Autoimmune acquired coagulation factor deficiency
189 clinical trials,   219 drugs   (DrugBank: 29 drugs),   18 drug target genes,   26 drug target pathways

Searched query = "Autoimmune acquired coagulation factor deficiency", "Coagulation factor deficiency", "Factor XIII deficiency", "Factor VIII deficiency", "Acquired hemophilia A", "von Willebrand Disease", "Factor V deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2006-002857-54-DE
(EUCTR)
10/11/200610/08/2006International clinical study to investigate the efficacy and safety of Wiloctin in patients with inherited von willebrand disease (vWD)International clinical study to investigate the efficacy and safety of Wiloctin in patients with inherited von willebrand disease (vWD) von Willebrand Jürgends syndrom in children under 6 years of ageTrade Name: WILATE
Product Name: Wiloctin
Octapharma AGNULLNot RecruitingFemale: yes
Male: yes
50Germany